KCNIP2 is a regulatory subunit of Kv4/D-type voltage-gated A-type potassium channels that modulates channel density, inactivation kinetics, and recovery rates from inactivation in a calcium-dependent manner 123456. It facilitates trafficking of KCND2 and KCND3 channels to the cell surface 7 and is essential for cardiac I(To) current expression. In cardiac electrophysiology, KCNIP2 dysregulation contributes to arrhythmias and heart failure; notably, Notch pathway activation in atrial fibrillation reduces Kcnip2 expression alongside other ion channel genes, altering action potential duration chamber-specifically 8. Beyond the heart, KCNIP2-expressing inhibitory interneurons in the spinal dorsal horn regulate cold sensitivity through modulation of nociceptive pathways 9. KCNIP2 shows tissue-specific alternative splicing patterns with distinct neuronal expression profiles 10. Clinically, KCNIP2-AS1 (an antisense lncRNA) exhibits reduced expression in breast cancer and correlates inversely with tumor grade and mitotic rates, suggesting potential tumor-suppressive function 11. Additionally, KCNIP2 undergoes DNA methylation changes in autism spectrum disorder models that correlate between brain and peripheral blood tissues 12. These diverse roles position KCNIP2 as a multifunctional regulator in cardiac and neurological physiology with emerging relevance to oncology.